179 related articles for article (PubMed ID: 37685842)
1. Tiliroside Combined with Anti-MUC1 Monoclonal Antibody as Promising Anti-Cancer Strategy in AGS Cancer Cells.
Radziejewska I; Supruniuk K; Jakimiuk K; Tomczyk M; Bielawska A; Galicka A
Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37685842
[TBL] [Abstract][Full Text] [Related]
2.
Radziejewska I; Supruniuk K; Tomczyk M; Izdebska W; Borzym-Kluczyk M; Bielawska A; Bielawski K; Galicka A
Int J Mol Sci; 2022 Aug; 23(15):. PubMed ID: 35955735
[TBL] [Abstract][Full Text] [Related]
3. Anti-cancer effect of combined action of anti-MUC1 and rosmarinic acid in AGS gastric cancer cells.
Radziejewska I; Supruniuk K; Bielawska A
Eur J Pharmacol; 2021 Jul; 902():174119. PubMed ID: 33930385
[TBL] [Abstract][Full Text] [Related]
4. Combined Action of Anti-MUC1 Monoclonal Antibody and Pyrazole-Platinum(II) Complexes Reveals Higher Effectiveness towards Apoptotic Response in Comparison with Monotherapy in AGS Gastric Cancer Cells.
Supruniuk K; Czarnomysy R; Muszyńska A; Radziejewska I
Pharmaceutics; 2021 Jun; 13(7):. PubMed ID: 34206951
[TBL] [Abstract][Full Text] [Related]
5. An essential epitope of anti-MUC1 monoclonal antibody KL-6 revealed by focused glycopeptide library.
Ohyabu N; Hinou H; Matsushita T; Izumi R; Shimizu H; Kawamoto K; Numata Y; Togame H; Takemoto H; Kondo H; Nishimura S
J Am Chem Soc; 2009 Dec; 131(47):17102-9. PubMed ID: 19899793
[TBL] [Abstract][Full Text] [Related]
6. Enhancement of reactivity of anti-MUC1 core protein antibody and killing activity of anti-MUC1 cytotoxic T cells by deglycosylation of target tissues or cells.
Hinoda Y; Takahashi T; Hayashi T; Suwa T; Makiguchi Y; Itoh F; Adachi M; Imai K
J Gastroenterol; 1998 Apr; 33(2):164-71. PubMed ID: 9605944
[TBL] [Abstract][Full Text] [Related]
7. Novel O-linked glycans containing 6'-sulfo-Gal/GalNAc of MUC1 secreted from human breast cancer YMB-S cells: possible carbohydrate epitopes of KL-6(MUC1) monoclonal antibody.
Seko A; Ohkura T; Ideo H; Yamashita K
Glycobiology; 2012 Feb; 22(2):181-95. PubMed ID: 21880669
[TBL] [Abstract][Full Text] [Related]
8. Expression of MUC1 and MUC2 mucins in gastric carcinomas: its relationship with the prognosis of the patients.
Utsunomiya T; Yonezawa S; Sakamoto H; Kitamura H; Hokita S; Aiko T; Tanaka S; Irimura T; Kim YS; Sato E
Clin Cancer Res; 1998 Nov; 4(11):2605-14. PubMed ID: 9829723
[TBL] [Abstract][Full Text] [Related]
9. MUC1 glycoforms in breast cancer--cell line T47D as a model for carcinoma-associated alterations of 0-glycosylation.
Hanisch FG; Stadie TR; Deutzmann F; Peter-Katalinic J
Eur J Biochem; 1996 Feb; 236(1):318-27. PubMed ID: 8617281
[TBL] [Abstract][Full Text] [Related]
10. Thomsen-Friedenreich antigen expression in gastric carcinomas is associated with MUC1 mucin VNTR polymorphism.
Santos-Silva F; Fonseca A; Caffrey T; Carvalho F; Mesquita P; Reis C; Almeida R; David L; Hollingsworth MA
Glycobiology; 2005 May; 15(5):511-7. PubMed ID: 15604091
[TBL] [Abstract][Full Text] [Related]
11. Identification of a novel cancer-specific immunodominant glycopeptide epitope in the MUC1 tandem repeat.
Tarp MA; Sørensen AL; Mandel U; Paulsen H; Burchell J; Taylor-Papadimitriou J; Clausen H
Glycobiology; 2007 Feb; 17(2):197-209. PubMed ID: 17050588
[TBL] [Abstract][Full Text] [Related]
12. Products of Chemoenzymatic Synthesis Representing MUC1 Tandem Repeat Unit with T-, ST- or STn-antigen Revealed Distinct Specificities of Anti-MUC1 Antibodies.
Yoshimura Y; Denda-Nagai K; Takahashi Y; Nagashima I; Shimizu H; Kishimoto T; Noji M; Shichino S; Chiba Y; Irimura T
Sci Rep; 2019 Nov; 9(1):16641. PubMed ID: 31719620
[TBL] [Abstract][Full Text] [Related]
13. Anti-cancer effects of pyrazole-platinum(II) complexes combined with anti-MUC1 monoclonal antibody versus monotherapy in DLD-1 and HT-29 colon cancer cells.
Supruniuk K; Czarnomysy R; Muszyńska A; Radziejewska I
Transl Oncol; 2022 Apr; 18():101348. PubMed ID: 35121220
[TBL] [Abstract][Full Text] [Related]
14. A novel monoclonal antibody specific for sialylated MUC1 mucin.
Yamamoto M; Bhavanandan VP; Nakamori S; Irimura T
Jpn J Cancer Res; 1996 May; 87(5):488-96. PubMed ID: 8641986
[TBL] [Abstract][Full Text] [Related]
15. The ST6GalNAc-I sialyltransferase localizes throughout the Golgi and is responsible for the synthesis of the tumor-associated sialyl-Tn O-glycan in human breast cancer.
Sewell R; Bäckström M; Dalziel M; Gschmeissner S; Karlsson H; Noll T; Gätgens J; Clausen H; Hansson GC; Burchell J; Taylor-Papadimitriou J
J Biol Chem; 2006 Feb; 281(6):3586-94. PubMed ID: 16319059
[TBL] [Abstract][Full Text] [Related]
16. Expression of MUC1, MUC2 and oligosaccharide epitopes in breast cancer: prognostic significance of a sialylated MUC1 epitope.
Baldus SE; Wienand JR; Werner JP; Landsberg S; Drebber U; Hanisch FG; Dienes HP
Int J Oncol; 2005 Nov; 27(5):1289-97. PubMed ID: 16211224
[TBL] [Abstract][Full Text] [Related]
17. Expression of MUC1 and MUC2 mucins by human tumor cell lines.
Devine PL; Birrell GW; Whitehead RH; Harada H; Xing PX; McKenzie IF
Tumour Biol; 1992; 13(5-6):268-77. PubMed ID: 1283926
[TBL] [Abstract][Full Text] [Related]
18. Influence of monoclonal anti-Lewis b, anti-H type 1, and anti-sialyl Lewis x antibodies on binding of Helicobacter pylori to MUC1 mucin.
Radziejewska I; Leszczyńska K; Borzym-Kluczyk M
Mol Cell Biochem; 2014 Jan; 385(1-2):249-55. PubMed ID: 24096735
[TBL] [Abstract][Full Text] [Related]
19. Targeting of Tumor-Associated Glycoforms of MUC1 with CAR T Cells.
Maher J; Wilkie S; Davies DM; Arif S; Picco G; Julien S; Foster J; Burchell J; Taylor-Papadimitriou J
Immunity; 2016 Nov; 45(5):945-946. PubMed ID: 27851917
[TBL] [Abstract][Full Text] [Related]
20. Lack of polymorphism in MUC1 tandem repeats in cancer cells is related to breast cancer progression in Japanese women.
Kawaguchi T; Takazawa H; Imai S; Morimoto J; Watanabe T
Breast Cancer Res Treat; 2005 Aug; 92(3):223-30. PubMed ID: 16155793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
